Alpha 2.0
Login Register
» Journals » Eur J Surg Oncol

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

The European Journal of Surgical Oncology is the official journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. It publishes high-quality research articles, reviews, and case reports in the field of surgical oncology, covering a wide range of topics including diagnosis, treatment, and management of cancer. The journal aims to promote the exchange of knowledge and advancements in surgical oncology across Europe and beyond.
Details
Abbr. Eur J Surg Oncol
Publisher Elsevier
Start 1985
End Continuing
Frequency Monthly, 2008-
p-ISSN 0748-7983
e-ISSN 1532-2157
Country United Kingdom
Language English
Specialties General Surgery
Oncology
Metrics
h-index / Ranks: 2345 117
SJR / Ranks: 2962 1164
CiteScore / Ranks: 3428 6.40
JIF / Ranks: 2461 3.8
Recent Articles
1.
Palliative management of patients with locally recurrent rectal cancer: Clinical presentation, treatment strategies, and overall survival
Banken E, Creemers D, Kerckhove F, Ketelaers S, van Hellemond I, Peulen H, et al.
Eur J Surg Oncol . 2025 Mar; 51(7):109758. PMID: 40088728
Introduction: Locally recurrent rectal cancer (LRRC) occurs in 6-12 % of the patients after curative treatment for primary rectal cancer. Palliative treatment plays a critical role, as over half of...
2.
Comment on "Evaluating the feasibility of repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence: Technical considerations and oncologic outcomes"
Xu M, Zhu X, Zhu J, Zhen L
Eur J Surg Oncol . 2025 Mar; 51(7):109741. PMID: 40088727
No abstract available.
3.
Reply to comment on Indocyanine green highlights the lymphatic drainage pathways, enhancing the effectiveness of radical surgery for mid-low rectal cancer: A non-randomized controlled prospective study
Qiu W
Eur J Surg Oncol . 2025 Mar; 51(7):109744. PMID: 40088726
No abstract available.
4.
Comment on: Indocyanine green highlights the lymphatic drainage pathways, enhancing the effectiveness of radical surgery for mid-low rectal cancer: A non-randomized controlled prospective study
Kehagias D, Lampropoulos C, Kehagias I
Eur J Surg Oncol . 2025 Mar; 51(7):109743. PMID: 40088725
No abstract available.
5.
Outcomes following inferior vena cava reconstruction at an advanced surgical unit
Younan E, Risbey C, Ye L, Karunaratne S, Seyfi D, Steffens D, et al.
Eur J Surg Oncol . 2025 Mar; 51(7):109740. PMID: 40088724
Background: Inferior vena cava (IVC) resection and reconstruction is a viable option for managing complex intra-abdominal tumours. This study evaluates the impact of surgical approach to IVC reconstruction on early...
6.
An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from the German Cancer Registry Group
von Fritsch L, Duhn J, Abdalla T, Honselmann K, Bolm L, Braun R, et al.
Eur J Surg Oncol . 2025 Mar; 51(6):109693. PMID: 40088502
Background: To date surgical resection is the only curative treatment option for pancreatic ductal adenocarcinoma (PDAC). However, survival rates are poor. Resection margins have long been used as a surrogate...
7.
Validation of the Iwate scoring system for the stratification of laparoscopic liver resections: An international multicenter study
Peng Y, Liu F, Li B, Wei Y, Tan H, Syn N, et al.
Eur J Surg Oncol . 2025 Mar; 51(6):109597. PMID: 40088501
Introduction: The Iwate difficulty scoring system (DSS) is one of the most widely validated DSS for laparoscopic liver resection (LLR). However, these studies only validated the 4 difficulty levels and...
8.
Colorectal liver metastasis resection results in excellent long-term quality of life and low symptom burden
Bhimani N, Dieng M, Kelly P, Hugh T
Eur J Surg Oncol . 2025 Mar; 51(7):109751. PMID: 40086219
Introduction: Prognostic factors in patients who undergo liver resection for colorectal liver metastases (CRLM) have been investigated, but limited research exists on health-related quality of life (HRQoL), functional status, and...
9.
The survival and prognostic factors of head and neck cancer patients over the age of 80 in comparison to their younger counterparts: Cohort study
Masseron A, AlAyadhi D, Blanc J, Fuchsmann C, Lapierre A, Ceruse P, et al.
Eur J Surg Oncol . 2025 Mar; 51(7):109755. PMID: 40086218
Objective: The aim of this study was to compare the overall survival and prognostic factors of patients ≥80 years old with those of patients aged 70-79 years who were diagnosed...
10.
Is total mesorectal excision mandatory in advanced ovarian cancer patients undergoing posterior pelvic exenteration? Prognostic role of mesorectal space involvement in a prospective ovarian cancer cohort
Ferraioli D, Fuso L, Chiado F, Russo C, Rossi L, Borella F, et al.
Eur J Surg Oncol . 2025 Mar; 51(7):109749. PMID: 40086217
Introduction: In advanced epithelial ovarian cancer (AEOC), debulking surgery with posterior pelvic exenteration (PPE) is performed in 35-70 % of the patients to achieve no macroscopic residual disease. This study...